天美传媒

Pushan Jani, MD, associate professor of pulmonary and sleep medicine at McGovern Medical School at UTHealth in Houston, has been keeping up with the rise of tobacco substitutes such as e-cigarettes and is available to comment on this development. E-cigarettes produce an aerosol by heating a liquid that usually contains nicotine—the addictive drug in regular cigarettes, cigars, and other tobacco products—flavorings, and other chemicals that help to make the aerosol, according to the Centers for Disease Control and Prevention. Users inhale this aerosol into their lungs. Bystanders can also breathe in this aerosol when the user exhales into the air. Jani, who is also affiliated with Memorial Hermann-Texas Medical Center and UT Physicians, has several issues with the tobacco substitutes. According to published research data, the flavoring agents used in vaping products can cause inflammation and damage to the lungs. While there is no tobacco, users are still getting nicotine. The impact of vaping to bystanders is not known. In practice since 2007, Jani is a full-time interventional pulmonologist and bedside educator. Jani’s clinical expertise is in procedural care, including electromagnetic navigational bronchoscopy, endobronchial ultrasound-guided biopsies (EBUS), transtracheal oxygen catheter insertions, and percutaneous dilatational tracheostomy. Jani can also speak about hazardous conditions after chemical fires and other disasters.

Sean is an assistant professor in pulmonary and critical care medicine who originally hails from the Commonwealth of Virginia. His clinical and research interests include care for patients with complex lung disease, with a focus on idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. He sees patients at the Farmington and University Hospital pulmonary clinics. He has expertise in the pulmonary care and pathology of patients with the deadly illness caused by vaping, e-cigarette or vaping use associated with lung injury (EVALI), and with COVID-19.

, is a board-certified pulmonologist who treats patients with a variety of respiratory conditions. His interests include pulmonary vascular disease, critical care medicine, and pulmonary vascular malformations such hereditary hemorrhagic telangiectasia (a disorder that affects blood vessels).
He has treated many patients with COVID-19 and led efforts to assist health care professionals in Tijuana during the pandemic.
Mandel is the Kenneth M. Moser Professor of Medicine at the UC San Diego School of Medicine and chief of the Pulmonary, Critical Care and Sleep Medicine Division and serves as vice chair for education in the Department of Internal Medicine.
Mandel was honored with a Presidential Citation by the San Diego County Medical Society for his involvement in their COVID response. More significantly, he helped organize relief efforts in Tijuana and Mexicali, reducing the cross-border spread of COVID and saving hundreds of lives.
He is active in several leadership roles with the American Thoracic Society, including serving as chair of their international conference.